NCT05150600

Brief Summary

Background and Objectives: Maintaining oxygenation during neonatal open repair of esophageal atresia is difficult. Inverse ratio ventilation can be used during one lung ventilation (OLV) to improve the oxygenation and lung mechanics. The investigators will compare inverse ratio to conventional ratio ventilation during OLV in neonatal open repair of esophageal atresia regarding effect in oxygenation, hemodynamic variables, incidence of complications, and easiness of procedure. Methods: The investigators will enroll 40 term neonates undergoing open right thoracotomy for esophageal atresia repair in this prospective randomized study. The patients will be randomly assigned into 2 groups based on inspiratory to expiratory (I:E) ratio of mechanical ventilation parameters (I:E ratio will be 2:1 in IRV and 1:2 in CRV). The incidence of desaturation episodes that needs to stop the procedure and reinflation of the lung will recorded as the primary outcome while hemodynamic parameters, incidence of complications, and length of surgical procedure will be recorded as the secondary outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 15, 2021

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

November 12, 2021

Completed
27 days until next milestone

First Posted

Study publicly available on registry

December 9, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
Last Updated

July 25, 2022

Status Verified

July 1, 2022

Enrollment Period

6 months

First QC Date

November 12, 2021

Last Update Submit

July 21, 2022

Conditions

Keywords

Inverse ratio VentilationNeonatesEsophageal atresia/Tracheoesophageal fistulaone lung ventilation

Outcome Measures

Primary Outcomes (1)

  • Incidence of severe desaturation episodes

    Incidence of desaturation episodes that needs to stop the procedure and reinflation of the retracted lung.

    6 months

Secondary Outcomes (5)

  • Mean blood pressure

    6 months

  • Incidence of complications

    6 months

  • Length of surgical procedure

    6 months

  • Heart rate

    6 months

  • Oxygen saturation

    6 months

Study Arms (2)

Group Inverse Ratio Ventilation (IRV)

EXPERIMENTAL

The inspiratory to expiratory (I:E) ratio in this group will be 2:1 with the maximum inspiratory time (Ti) of 1.3 seconds

Procedure: Inverse Ratio Ventilation

Group Conventional Ratio Ventilation (CRV)

NO INTERVENTION

The inspiratory to expiratory (I:E) ratio in this group will be 1:2 with the minimum inspiratory time (Ti) of 0.4 seconds

Interventions

The inspiratory to expiratory (I:E) ratio will be reversed to be 2:1 during mechanical ventilation

Group Inverse Ratio Ventilation (IRV)

Eligibility Criteria

AgeUp to 28 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • The patients will be of ASA physical status II-III, neonates aged less than 28 days and undergoing open repair of esophageal atresia/tracheoesophageal fistula with right thoracotomy. All patients' will be full term with gestational age ≥ 36 weeks and weigh ≥ 2.5 kilograms.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain shams university- faculty of medicine- department of anesthesia, intensive care and pain management

Cairo, Egypt

Location

MeSH Terms

Conditions

Tracheoesophageal Fistula

Condition Hierarchy (Ancestors)

Esophageal FistulaDigestive System FistulaDigestive System DiseasesEsophageal DiseasesGastrointestinal DiseasesRespiratory Tract FistulaRespiratory Tract DiseasesTracheal DiseasesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Akram Amer, MD

    Ain Shams University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer in the department of Anesthesia

Study Record Dates

First Submitted

November 12, 2021

First Posted

December 9, 2021

Study Start

October 15, 2021

Primary Completion

March 30, 2022

Study Completion

June 30, 2022

Last Updated

July 25, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will share

Data obtained through the study may be provided to qualified researchers with academic interest in neonatal anesthesia. Data shared will be coded, with no patient health information included.

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
Data requests can be submitted starting 6 months after article publication and the data will be made accessible for up to 24 months. Extensions will be considered on a case-by-case basis.
Access Criteria
Access to trial IPD can be requested by qualified researchers engaging in independent scientific research. For more information or to submit a request, please contact akram.amer@med.asu.edu.eg

Locations